Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,276 | -8,877 | -3,864 | -11,136 | -8,309 |
| Depreciation Amortization | 867 | 483 | 177 | 581 | 437 |
| Accounts receivable | -770 | -269 | -288 | -228 | -252 |
| Accounts payable and accrued liabilities | 948 | 608 | 109 | -1,048 | -1,070 |
| Other Working Capital | 1,244 | 445 | -426 | -2,940 | -2,621 |
| Other Operating Activity | 536 | 320 | 496 | 2,080 | 2,064 |
| Operating Cash Flow | $-11,451 | $-7,290 | $-3,796 | $-12,691 | $-9,751 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -810 | -893 | -122 | -568 | -403 |
| Net Acquisitions | -5,135 | -5,135 | N/A | N/A | N/A |
| Investing Cash Flow | $-5,945 | $-6,028 | $-122 | $-568 | $-403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,225 | 9,642 | N/A | N/A | 0 |
| Debt Repayment | -114 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,949 | 2,655 | N/A | 19,237 | 15,737 |
| Other Financing Activity | -837 | -837 | 0 | -1,361 | -915 |
| Financing Cash Flow | $14,223 | $11,460 | $0 | $17,876 | $14,822 |
| Beginning Cash Position | 6,260 | 6,260 | 6,260 | 1,643 | 1,643 |
| End Cash Position | 3,087 | 4,402 | 2,342 | 6,260 | 6,311 |
| Net Cash Flow | $-3,173 | $-1,858 | $-3,918 | $4,617 | $4,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,451 | -7,290 | -3,796 | -12,691 | -9,751 |
| Capital Expenditure | -810 | -893 | -122 | -568 | -403 |
| Free Cash Flow | -12,261 | -8,183 | -3,918 | -13,259 | -10,154 |